Comparison of Safety and Efficacy between Venetoclax Combined with CAG (cytarabine, aclarubicin, G-CSF) Regimen and CAG Regimen Alone in Patients with Relapsed or Refractory Acute Myeloid Leukemia

被引：2
|
作者：
Yu, Wen-Jing [1 ]
Wu, Ying [1 ]
Chen, Qi [1 ]
Zhu, Xiaolu [1 ]
Pei, Xu-Ying [1 ]
Jia, Jin-Song [2 ]
Wang, Jing [1 ]
Zhao, Xiao-Su [1 ]
Chang, Ying-Jun [1 ]
Lai, Yue-Yun [1 ]
Shi, Hong-Xia [1 ]
Ruan, Guo-Rui [1 ]
Qin, Ya-Zhen [1 ]
Liu, Xiao-Hong [1 ]
Huang, Xiao Jun [1 ,3 ]
Jiang, Hao [1 ]
机构：
[1] Peking Univ, Beijing Key Lab Hematopoiet Stem Cell Transplanta, Inst Hematol, Natl Clin Res Ctr Hematol Dis,Peoples Hosp, Beijing, Peoples R China
[2] Peking Univ, Inst Hematol, Peoples Hosp, Beijing, Peoples R China
[3] Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-184665
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Increasing the dose of aclarubicin in low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) can safely and effectively treat relapsed or refractory acute myeloid leukemia
    Limin Liu
    Yanming Zhang
    Zhengming Jin
    Xingxia Zhang
    Guangsheng Zhao
    Yejun Si
    Guoqiang Lin
    Aidi Ma
    Yingxin Sun
    Li Wang
    Depei Wu
    International Journal of Hematology, 2014, 99 : 603 - 608
  • [22] Comparison of Salvage Intensive Chemotherapy Versus Venetoclax Combined Regimen in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML)
    Park, Silvia
    Kim, Hee-Je
    Cho, Byung Sik
    Kim, Yoo-Jin
    Min, Gi June
    Park, Sung-Soo
    Yahng, Seung-Ah
    Jeon, Young-Woo
    Shin, Seung-Hwan
    Yoon, Jae-Ho
    Lee, Sung-Eun
    Eom, Ki-Seong
    Lee, Seok
    Min, Chang-Ki
    Cho, Seok-Goo
    Lee, Jong Wook
    BLOOD, 2021, 138
  • [23] Comparison of clinical efficacy between decitabine combined with half the amount of CAG regimen with CAG regimen alone in patients with inermediate to high-risk myelodysplastic syndrome
    Fen, Zhenwei
    Wang, Xuan
    Zhao, Chunshan
    Wang, Wei
    Yu, Tingting
    2016 INTERNATIONAL CONFERENCE ON MEDICINE SCIENCES AND BIOENGINEERING (ICMSB2016), 2017, 8
  • [24] Modified cladribine, cytarabine, and G-CSF as a salvage regimen in patients with relapsed/refractory acute myeloid leukemia: a bridge to myeloablative allogeneic hematopoietic stem cell transplantation
    Ye, Peipei
    Pei, Renzhi
    Jin, Jie
    Sun, Jie
    Li, Kongfei
    Cao, Junjie
    Zhou, Dandan
    Lu, Ying
    ANNALS OF HEMATOLOGY, 2019, 98 (09) : 2073 - 2080
  • [25] Modified cladribine, cytarabine, and G-CSF as a salvage regimen in patients with relapsed/refractory acute myeloid leukemia: a bridge to myeloablative allogeneic hematopoietic stem cell transplantation
    Peipei Ye
    Renzhi Pei
    Jie Jin
    Jie Sun
    Kongfei Li
    Junjie Cao
    Dandan Zhou
    Ying Lu
    Annals of Hematology, 2019, 98 : 2073 - 2080
  • [26] Efficacy of high-dose cytarabine and aclarubicin in combination with G-CSF regimen compared to intermediate/high-dose cytarabine and standard-dose cytarabine induction regimen for non-remission acute myeloid leukemia
    Lei, Meiqing
    Liu, Limin
    Wang, Zhiming
    Wu, Depei
    INDIAN JOURNAL OF CANCER, 2019, 56 (02) : 167 - 172
  • [27] Efficacy and safety of decitabine combined with HAAG (homoharringtonine, aclarubicin, low-dose cytarabine and G-CSF) for newly diagnosed acute myeloid leukemia
    Zhu, Jun-Feng
    Dai, Hai-Ping
    Zhang, Qian-Qian
    Yin, Jia
    Li, Zheng
    Cui, Qin-Ya
    Tian, Xiao-Peng
    Liu, Si-Ning
    Jin, Zheng-Ming
    Zhu, Xia-Ming
    Wu, De-Pei
    Tang, Xiao-Wen
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [28] Efficacy and Safety of C-CAG Regimen (cladribine in combination with granulocyte colony-stimulating factor, low-dose cytarabine and aclarubicin) in Patients with Refractory/Relapsed Acute Myeloid Leukemia: A Phase 2, Single Center, Single Arm Study
    Wang, Hua
    Lu, Yue
    BLOOD, 2018, 132
  • [29] EFFICACY AND SAFETY OF ETOPOSIDE IN COMBINATION WITH G-CSF, LOW-DOSE CYTARABINE AND ACLARUBICIN IN NEWLY DIAGNOSED ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA
    Gao, L.
    Feng, Y. M.
    Yan, H. J.
    Zhang, Y. Q.
    Zhang, C.
    Gao, L.
    Kong, P. Y.
    Liu, Y.
    Zhu, L. D.
    Zeng, Y. J.
    Rao, J.
    Su, Y.
    Yang, T. H.
    Wang, S. B.
    Li, H. M.
    Lou, S. F.
    Zhang, X.
    HAEMATOLOGICA, 2016, 101 : 387 - 387
  • [30] A retrospective comparison of salvage intensive chemotherapy versus venetoclax-combined regimen in patients with relapsed/refractory acute myeloid leukemia (AML)
    Park, Silvia
    Kwag, Daehun
    Kim, Tong Yoon
    Lee, Jong Hyuk
    Lee, Joon Yeop
    Min, Gi June
    Park, Sung Soo
    Yahng, Seung-Ah
    Jeon, Young-Woo
    Shin, Seung-Hwan
    Yoon, Jae-Ho
    Lee, Sung-Eun
    Cho, Byung Sik
    Eom, Ki-Seong
    Kim, Yoo-Jin
    Lee, Seok
    Min, Chang-Ki
    Cho, Seok-Goo
    Lee, Jong Wook
    Kim, Hee-Je
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2022, 13
12345